MENU
OCT 4 - 6 2022 Opens: 6:00 AM PDT

Cancer Research & Immuno-Oncology Week 2022

Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roof at our 10th annual Cancer Research & Immuno-Oncology Week, hosted on October 4-6, 2022.  

Cancer Research & Immuno-Oncology Week 2022 will offer a 3-day content-rich program providing invited lectures, thought-provoking discussions and posters to explore global developments and advancements in the prevention, diagnosis, and treatment of different cancer types. Each year, we see progress in immunotherapy and treatments in targeted and personalized therapeutics and drug development, and a decrease in mortality rates due to a strong focus on learning more about the origination of the disease.

Recent breakthroughs in immuno-oncology research translate into a paradigm shift to attacking cancer, and the benefits of immuno-oncology have resulted in long-lasting tumor regression where surgery, radiotherapy, chemotherapy, and targeted therapy proved less effective. As immuno-oncology is considered by some to be one of the most promising areas of research in the world of anti-cancer therapeutics, you'll also learn from experts how immunotherapies can work alone, together, or in a combination with other treatments to fight cancer.

Last year's tracks included the following:

Cancer Research:

  • The Role of Evolution and Evolutionary Medicine in Understanding Drug and Radiation Resistance of Cancer
  • The Latest in Immunotherapy and Other Novel Cancer Therapeutics
  • Health Disparities: How Cancer Impacts the Underrepresented and Underserved
  • Integrating Genetics into Standard of Care and Precision Medicine
  • The Role of the Tumor Stromal Microenvironment in Tumor Dormancy and Resistance to Therapy

Immuno-Oncology:

  • New Advancements in Immuno-Oncology
    • Cell Therapy Innovation
    • Checkpoint Inhibitors
    • Innate Immunity Considerations
    • Microbiome and Cancer
    • New Adaptive Immunity Considerations
  • Emerging Targets for Immuno-Oncology Therapy
    • Overcoming Obstacles in the Immunosuppressive Tumor Micro-environment
    • Molecular and Epigenetic Modulation
    • Cancer Immunotherapeutics and COVID-19
    • Novel Cell Therapy Targets and Engineering Strategies
  • Advancing Cancer Immunotherapies to the Clinic
    • Translational
    • Clinical

Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2021 Cancer Research and Oncology Virtual Event. Submission is free. Submit your abstract here.

Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing.  This virtual conference also offers increased reach for the global cancer research and immuno-oncology community with a high degree of interaction through live-streaming video and chat sessions.

Continuing Education
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 35 credits.

Use #LRcancer to follow the conversation!



Show Resources
You May Also Like
NOV 09, 2022 6:00 AM PST
NOV 09, 2022 6:00 AM PST
Labroots is pleased to host the annual 2022 Clinical Diagnostics and Research virtual event to be held on November 9th, 2022. Registration is open now....
NOV 09, 2023 6:00 AM PST
NOV 09, 2023 6:00 AM PST
Labroots is pleased to announce the 2023 Clinical Diagnostics and Research Virtual Event to be held on November 9th, 2023 packed with featured speakers....
SEP 06, 2022 6:00 AM PDT
SEP 06, 2022 6:00 AM PDT
Labroots to host the Microbiology Virtual Week on September 6, 2022. It offers discussions on the global development of treatment for Infectious Diseases....
SEP 05, 2023 6:00 AM PDT
SEP 05, 2023 6:00 AM PDT
Labroots to host the Microbiology Virtual Week on September 5-7, 2023. Offering discussions on the global development of treatment for Infectious Diseases....
MAY 16, 2023 6:00 AM PDT
MAY 16, 2023 6:00 AM PDT
Labroots is excited to announce our 11th Genetics Virtual Week held on May 16-18, 2023! Genetics Virtual Week will offer a multi-day content-rich program....
APR 20, 2023 6:00 AM PDT
APR 20, 2023 6:00 AM PDT
Labroots is pleased to host the 6th 2023 Cannabis Sciences Virtual Event. Labroots will host the event on April 20, 2023, filled with featured speakers....
Sponsored by

For information on becoming a sponsor or exhibitor, please click here.


Committee

To download the Program Committee brochure here.


  • Antonio Baines

    Dr. Antonio T. Baines is an Associate Professor in the Department of Biology at North Carolina Central University (NCCU) and an adjunct professor in the Department of Pharmacology in the School of Medicine at the University of North Carolina (UNC) Chapel Hill. He earned a ...

    See more See less
  • Rajan Gupta

    Dr. Rajan T. Gupta, MD, is an Assistant Professor of Radiology in the Division of Abdominal Imaging at Duke University Medical Center, as well as the Director of the Abdominal Imaging Fellowship Program and a Faculty physician in the Duke Cancer Institute. Since 2009, he has been ...

    See more See less
  • Keith Knutson

    Keith L. Knutson, Ph.D., is a consultant in the Department of Immunology, Mayo Clinic in Florida, where he also serves as director of the Discovery and Translation Lab's Cancer Research Program. Dr. Knutson joined the staff of Mayo Clinic in 2005 and holds the academic rank of ...

    See more See less
  • Jonas Korlach

    Jonas Korlach was appointed Chief Scientific Officer of Pacific Biosciences in July 2012. He was previously a Scientific Fellow, supporting commercial development of the PacBio RS II system and performing research aimed at developing new applications for SMRT technologies. He ...

    See more See less
Help

Demographics

Loading Comments...
Show Resources
Event Countdown
  • 0 Days
  • 0 Hours
  • 0 Minutes
  • 0 Seconds